Literature DB >> 16724487

Testing for crossover of two hazard functions using Gail and Simon's method.

Y H Joshua Chen1, G H Frank Liu.   

Abstract

Crossover of two hazard functions is sometimes called qualitative nonproportionality where the hazard ratio could be >1 in some time intervals but <1 in some other intervals. Investigators often wish to know whether a beneficial treatment effect exists over a long period of time (i.e., no crossover). This information is important for the management of safety and efficacy of a new treatment in long-term use. Also, if crossover occurs, the commonly used statistical methods, such as Cox proportional hazards model or linear rank tests, may not be appropriate. Graphical display may be used to visually examine whether there are crossovers in the observed hazard functions. A relevant question is whether the observed crossover of two hazard functions is due to chance variation. In this article, we propose a class of tests for crossover of two hazard functions. The study follow-up period is divided into nonoverlapping time intervals, and the weighted linear rank statistic, including logrank and generalized Wilcoxon statistics, can be calculated from each interval. These statistics are asymptotically independent and have normal distributions. Treating each interval as a "patient subset," qualitative tests of interactions between treatment and patient subsets can naturally apply. For our purpose, we consider the likelihood ratio test proposed by Gail and Simon. Two examples are used to illustrate this approach. The proposed test procedures are also studied through simulations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16724487     DOI: 10.1080/10543400600614791

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  2 in total

1.  Escitalopram for older adults with generalized anxiety disorder: a randomized controlled trial.

Authors:  Eric J Lenze; Bruce L Rollman; M Katherine Shear; Mary Amanda Dew; Bruce G Pollock; Caroline Ciliberti; Michelle Costantino; Sara Snyder; Peichang Shi; Edward Spitznagel; Carmen Andreescu; Meryl A Butters; Charles F Reynolds
Journal:  JAMA       Date:  2009-01-21       Impact factor: 56.272

2.  Combined test versus logrank/Cox test in 50 randomised trials.

Authors:  Patrick Royston; Babak Choodari-Oskooei; Mahesh K B Parmar; Jennifer K Rogers
Journal:  Trials       Date:  2019-03-18       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.